Grant: Team Grant: HIV/AIDS Vaccine Discovery and Social Research - LOI
Université Laval
$24,950.00
Development and preclinical testing of a nanoparticle-based HIV-1 vaccine
EF 2010-11
Résumé
The proposed research is aimed at monitoring the ability of a plant virus-based adjuvant to increase the immunogenicity of HIV-1-derived Gag and Env recombinant proteins. This research will provide insightful data on the possibility to use this adjuvant in small animal and non-human primate models, paving the way for clinical trials in humans.
Programme
Team Grant: HIV/AIDS Vaccine Discovery and Social Research - LOI
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
218242
Name
Tremblay Michel J
Region
Québec
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
HIV/AIDS Vaccine Discovery and Social Research
Projecttitle
Development and preclinical testing of a nanoparticle-based HIV-1 vaccine
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$24,950
Cihrequipment2
$0
Programname2
Team Grant: HIV/AIDS Vaccine Discovery and Social Research - LOI
Keyworddelim
Adaptive Immunity; Adjuvant; Anaimal Model; Cytotoxic T Cell; Hiv-1 Vaccine; Immunogen; Innate Immunity; Neutralizing Antibody
Abstract
The proposed research is aimed at monitoring the ability of a plant virus-based adjuvant to increase the immunogenicity of HIV-1-derived Gag and Env recombinant proteins. This research will provide insightful data on the possibility to use this adjuvant in small animal and non-human primate models, paving the way for clinical trials in humans.
Competitiondate
201010
Approvedterm2
1 yr 0 mth
Pinamesdelim
Tremblay, Michel J; Glashoff, Richard H
Approvedterm
1 an 0 mois
Cihrcontribution2
HIV/AIDS~ $24,950~ $0~